LONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Oil & Gas – E&P industry. Companies recently under review include Vermilion Energy, NuVista Energy, PrairieSky Royalty, and Niko Resources. Get all of our free research reports by signing up at:

http://www.activewallst.com/register/

On Friday, February 24, 2017, at the end of trading session, the Toronto Exchange Composite index ended the day at 15,533.47, 1.57% lower, on a total volume of 424,456,704 shares.

Additionally, the Energy index was down by 3.20%, ending the session at 196.85.

Active Wall St. has initiated research reports on the following equities: Vermilion Energy Inc. (TSX: VET), NuVista Energy Ltd. (TSX: NVA), PrairieSky Royalty Ltd. (TSX: PSK), and Niko Resources Ltd. (TSX: NKO). Register with us now for your free membership and research reports at:

http://www.activewallst.com/register/

Vermilion Energy Inc.

Calgary, Canada headquartered Vermilion Energy Inc.’s stock edged 0.60% lower, to finish Friday’s session at $51.58 with a total volume of 609,459 shares traded. Vermilion Energy’s shares have surged 44.40% in the past one year. Shares of the Company, which acquires, explores, develops, and produces crude oil and natural gas in North America, Europe, and Australia, are trading below its 50-day and 200-day moving averages. Vermilion Energy’s 50-day moving average of $53.80 is above its 200-day moving average of $52.68. See our research report on VET.TO at:

http://www.activewallst.com/register/

NuVista Energy Ltd.

On Friday, shares in Calgary, Canada headquartered NuVista Energy Ltd. recorded a trading volume of 295,577 shares. The stock ended the day 5.67% lower at $5.99. NuVista Energy’s stock has surged 38.98% in the past one year. Shares of the Company, which explores, develops, and produces oil and natural gas reserves in Canada, are trading below its 50-day and 200-day moving averages. The stock’s 200-day moving average of $6.86 is above its 50-day moving average of $6.56. The complimentary research report on NVA.TO at:

http://www.activewallst.com/register/

PrairieSky Royalty Ltd.

On Friday, shares in Calgary, Canada headquartered PrairieSky Royalty Ltd. ended the session 0.40% higher at $29.90 with a total volume of 550,362 shares traded. PrairieSky Royalty’s shares have surged 39.92% in the past one year. The stock is trading above its 200-day moving average. Further, the stock’s 50-day moving average of $30.84 is greater than its 200-day moving average of $29.55. Shares of PrairieSky Royalty, which invests in oil and natural gas properties in Canada, are trading at a PE ratio of 533.93. Register for free and access the latest research report on PSK.TO at:

http://www.activewallst.com/register/

Niko Resources Ltd.

Calgary, Canada headquartered Niko Resources Ltd.’s stock closed the day flat at $0.11. The stock recorded a trading volume of 200,616 shares. Niko Resources’ shares have gained 10.00% in the last three months and 37.50% in the past one year. The company’s shares are trading above their 200-day moving average. Moreover, the stock’s 200-day moving average of $0.12 is greater than its 50-day moving average of $0.11. Shares of the Company, which engages in the exploration for, development, and production of oil and natural gas, are trading at a PE ratio of 0.03. Get free access to your research report on NKO.TO at:

http://www.activewallst.com/register/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 456016

NEW YORK, NY / ACCESSWIRE / February 27, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies is issuing a comprehensive report with no obligation on OWC Pharmaceutical Research Corp (OTCQB: OWCP). OWC Pharmaceutical, through its wholly owned subsidiary, One World Cannabis Ltd, conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. It is also developing unique delivery systems for effective delivery and dosage of medical cannabis. All its research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators.

The state of Israel has been supportive of cannabis study and scientific research since the 1960’s in renowned academic and research hospitals. The Medical Cannabis Unit under the Health Minister Office has been operating in Israel since 2003.

This full report takes an in-depth look at possible treatments from OWC’s pipeline READ MORE

Copy and paste to your browser may be required to view the report- http://tradersnewssource.com/owc-pharmaceutical/

OWCP Team & Facility is led by experienced professionals, having substantial experience in areas of medical cannabis, clinical research, healthcare management, international business and financial markets. This knowledge, alongside their commercial experience, is likely to help OWCP’s business risk profile.

In fact, Dr. Yehuda Baruch, who is leading OWCP’s overall operations as “chief scientist officer” and regulatory affairs, is a world-renowned Psychiatrist, who founded, implemented and headed the Israeli Medical Cannabis Unit under the Minister of Health for over 10 years.

Key Cannabis based products, IP owned by OWCP and possible influences for their securities is discussed here READ MORE

Copy and paste to your browser may be required to view the report- http://tradersnewssource.com/owc-pharmaceutical/

DISCLOSURE

Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TNS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a chartered financial analyst, for further information on analyst credentials, please email editor@tradersnewssource.com. Vikas Agrawal, a CFA® charter holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.tradersnewssource.com.

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer be featured on our coverage list, contact us via email between 09:30 EST to 16:00 EST from Monday through Friday at: editor@tradersnewssource.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT:

editor@tradersnewssource.com

SOURCE: Traders News Source

ReleaseID: 456040

Upcoming AWS Coverage on SORL Auto Parts

LONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. announces its post-earnings coverage on Co. (NYSE: GM). The Company reported its financial results for the fourth quarter fiscal 2016 (Q4 FY16) and full year 2016 (FY16) on February 07, 2017. The Detroit, Michigan-based Company’s quarterly total net sales and revenue grew 10.8% y-o-y, beating market consensus estimates. Register with us now for your free membership at:

http://www.activewallst.com/register/

One of General Motors’ competitors within the Auto Manufacturers – Major space, SORL Auto Parts, Inc. (NASDAQ: SORL), is estimated to report earnings on March 30, 2017. AWS will be initiating a research report on SORL Auto Parts following the release of its next earnings results.

Today, AWS is promoting its earnings coverage on GM; touching on SORL. Get our free coverage by signing up to:

http://www.activewallst.com/register/

Earnings Reviewed

In Q4 FY16, General Motors reported total net sales and revenue of $43.92 billion compared to $39.62 billion reported in Q4 FY15. Total net sales and revenue numbers for the reported quarter had outperformed market expectations of $42.20 billion.

The automobile Company reported GAAP net income attributable to stockholders of $1.84 billion, or $1.19 per diluted share, in Q4 FY16 compared to $6.27 billion, or $3.92 per diluted share, in Q4 FY15. The Company’s diluted adjusted EPS for the reported quarter stood at $1.28 per diluted share, declining $0.11 per diluted share from diluted adjusted EPS recorded in Q4 FY15. Wall Street had expected the Company to report diluted adjusted EPS of $1.14.

For full year FY16, General Motors’ revenue was $166.38 billion which came in 9.2% above the $152.36 billion reported in FY15. The Company reported net income attributable to stockholders of $9.43 billion, or $6.00 per diluted share in FY16 compared to $9.69 billion, or $5.91 per diluted share, in FY15. Additionally, the Company’s adjusted net income for FY16 stood at $9.61 billion, or $6.12 per diluted share, compared to $8.23 billion, or $5.02 per diluted share, in FY15.

Operating Metrics

During Q4 FY16, General Motors’ total operating segments profit stood at $2.82 billion compared to $3.00 billion in the previous year’s corresponding period. The segment’s adjusted EBIT came in at $2.39 billion in Q4 FY16 versus $2.77 billion in last year’s comparable quarter. Furthermore, in Q4 FY16, General Motors sold 2.78 million vehicles, up 3.3% on a y-o-y basis. In December 2016, the Company’s global volume of 1.05 million units was the highest in its history. For FY16, General Motors sold 3.04 million vehicles in the US and increased retail share by 0.5%.

Segment Performance

General Motors North America (GMNA) revenues rose to $31.29 billion during Q4 FY16 from $27.67 billion in the prior year’s same quarter. The segment’s adjusted EBIT fell to $2.6 billion in Q4 FY16 from $2.8 billion in Q4 FY15. Furthermore, adjusted EBIT margins were down to 8.4% in Q4 FY16 from 10.0% in the previous year’s same quarter.

In the reported period, General Motors Europe’s (GME) revenues fell to $4.42 billion from $4.7 billion in Q4 FY15. The segment reported a negative adjusted EBIT of $0.2 billion in Q4 FY16, narrower than negative adjusted EBIT of $0.3 billion recorded in the year ago comparable quarter.

During Q4 FY16, General Motors International Operations (GMIO) operations’ revenues were down to $3.28 billion from $3.45 billion in the last year’s same quarter. The segment’s Q4 FY16 adjusted EBIT was $0.3 billion, marginally falling from $0.4 billion in Q4 FY15.

General Motors South America (GMSA) segment’s revenues grew to $2.21 billion in Q4 FY16 from $1.88 billion in the prior’s year corresponding quarter. However, the segment reported a negative adjusted EBIT of $0.1 billion in Q4 FY16 compared to break-even results in Q4 FY15.

General Motors’ Financial segment revenues surged during Q4 FY16 to $2.69 billion from $1.88 billion in Q4 FY15. The segment’s EBIT for the reported quarter stood at $0.2 billion, which came in-line with EBIT numbers recorded in the year-ago same quarter.

Cash Flow & Balance Sheet

During the year ended on December 31, 2016, General Motors generated $16.55 billion in cash from operations compared to $11.69 billion at the end of quarter in the year ago same period. In the reported financial year, the Company’s adjusted automotive free cash flow was $6.87 billion versus $2.20 billion in FY15. The Company had cash and cash equivalents balance of $12.96 billion as on December 31, 2016, compared to $15.24 billion, at the close of books on December 31, 2015. Furthermore, the Company had Automotive long-term debt and Financial long-term debt amounting to $9.59 billion and $46.02 billion, respectively, as on December 31, 2016.

Dividend and Share Repurchases

On February 06, 2017, General Motors’ Board of Directors declared quarterly dividend of $0.38 per share payable on March 24, 2017, to shareholder of record at the close of business on March 10, 2017.

During Q4 FY16 the Company repurchased $1.0 billion shares totaling $2.5 billion shares buyback in full year FY16. Furthermore, the Company completed its first $5 billion share repurchase authorization and started the second share repurchase authorization of $4 billion.

Outlook

In its guidance for full year FY17, General Motors’ management expects diluted EPS and adjusted diluted EPS to be in the range of $6.00 to $6.50. Additionally, the Company projects a $15 billion in automotive operating cash flow; whereas adjusted automotive free cash flow for FY17 is anticipated to be $6 billion.

Stock Performance

On Friday, February 24, 2017, the stock closed the trading session at $36.90, marginally falling 0.94% from its previous closing price of $37.25. A total volume of 13.03 million shares have exchanged hands. General Motors’ stock price surged 10.32% in the last three months, 18.78% in the past six months, and 31.21% in the previous twelve months. Furthermore, since the start of the year, shares of the Company have gained 5.91%. The stock is trading at a PE ratio of 6.15 and has a dividend yield of 4.12%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 456018

Upcoming AWS Coverage on Garmin Post-Earnings Results

LONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. announces its post-earnings coverage on Fortive Corp. (NYSE: FTV). The Company announced its fourth quarter and fiscal 2016 financial results on February 07, 2017. Prior to July 02, 2016, Fortive operated as part of Danaher Corporation and the historical financial measures presented in the financial results prior to July 02, 2016, were derived from Danaher’s accounting records and presented on a carved-out basis. Register with us now for your free membership at:

http://www.activewallst.com/register/

One of Fortive’s competitors within the Scientific & Technical Instruments space, Garmin Ltd. (NASDAQ: GRMN), reported its Q4 2016 earnings results on Wednesday, February 22, 2017. AWS will be initiating a research report on Garmin in the coming days.

Today, AWS is promoting its earnings coverage on FTV; touching on GRMN. Get our free coverage by signing up to:

http://www.activewallst.com/register/

Earnings Reviewed

For the quarter ended December 31, 2016, Fortive reported that GAAP revenues increased 3.3% y-o-y to $1.6 billion, with core revenue growth of 3.5%.

For Q4 2016, Fortive’s net earnings were $224.5 million. For the same period, non-GAAP adjusted net earnings were $237.7 million. Diluted net earnings per share for Q4 2016 were $0.64, while non-GAAP adjusted diluted net earnings per share were $0.68.

James A. Lico, President and Chief Executive Officer, stated:

“We are pleased with our fourth quarter results as the team leveraged the power of the Fortive Business System to once again deliver core sales growth, cash flow generation, and earnings outperformance. We ended the year well-positioned for expected continued growth around the world and across our diverse businesses.”

Operating Metrics

During Q4 2016, Fortive’s operating profit margin was 20.8%, which reflects core adjusted operating margin expansion of 20 basis points. During the reported quarter, the Company generated approximately $278 million of free cash flow and delivered conversion ratio of 124%. For FY16, free cash flow conversion was 115%.

Segment Results

During Q4 2016, Fortive’s Professional Instrumentation posted core revenue growth of 1.2%, an acceleration of almost 50 basis points over Q3 2016, reflecting continued stabilization in North American industrial markets. FX was a significant headwind in the reported quarter, of approximately 130 basis points, which was partially offset by growth from acquisitions of 40 basis points. Professional Instrumentation’s operating profit margin was 23.1% in Q4 2016, reflecting a core operating margin decline of 30 basis points, driven primarily by long-term growth investments undertaken in the quarter, which was partially offset by decreased amortization.

Advanced Instrumentation & Solutions’ core revenue increased low single-digits, primarily led by good performance in both Fluke and Qualitrol, which comprise its Field Solutions platform. Field Solutions core revenue was up low single-digits in the reported quarter, with Fluke and Qualitrol posting low single-digit and high single-digit growth respectively.

For Q4 2016, Fortive’s Tektronix reported low single-digit core revenue growth, reflecting continued outperformance in China of high double-digits stabilization and developed markets. The Company’s Sensing Technologies platform posted high single-digit core growth in the reported quarter.

For its Industrial Technology segment, Fortive realized core revenue growth of 5.6% in Q4 2016. Acquisitions contributed approximately 130 basis points of growth, relative to prior year, which was partially offset by 100 basis points of unfavorable currency translation. The segment’s reported operating profit margin increased to 20.7%, and core operating margin was up 80 basis points for the quarter, reflecting margin expansion across all platforms.

Outlook

For Q1 2017, Fortive anticipates diluted net earnings per share to be in the range of $0.51 to $0.55 and the non-GAAP adjusted diluted net earnings per share to be in the range of $0.54 to $0.58. Fortive expects FY17 diluted net earnings per share to be in the range of $2.48 to $2.58 and non-GAAP adjusted diluted net earnings per share to be in the range of $2.60 to $2.70.

Stock Performance

On Friday, February 24, 2017, the stock closed the trading session at $57.79, slightly rising 0.93% from its previous closing price of $57.26. A total volume of 1.84 million shares have exchanged hands, which was higher than the 3-month average volume of 1.60 million shares. Fortive’s stock price advanced 4.88% in the last month, 4.50% in the past three months, and 12.78% in the previous six months. Furthermore, since the start of the year, shares of the Company have gained 7.89%. The stock is trading at a PE ratio of 23.00 and has a dividend yield of 0.48%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 456031

Upcoming AWS Coverage on BioMarin Pharmaceutical Post-Earnings Results

LONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. blog coverage looks at the headline from Chapel Hill, North Carolina-based Cempra, Inc. (NASDAQ: CEMP) as the Company announced on February 24, 2017, positive Phase-3 trial results of oral fusidic acid for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The Company noted that Fusidic acid was well tolerated in the study and achieved the primary endpoint, demonstrating non-inferiority (NI) of oral fusidic acid compared to oral linezolid for early clinical response (ECR) in the intent to treat (ITT) patient population. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of Cempra’s competitors within the Biotechnology space, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), reported on February 23, 2017, financial results for the fourth quarter and year ended December 31, 2016. AWS will be initiating a research report on BioMarin Pharma in the coming days.

Today, AWS is promoting its blog coverage on CEMP; touching on BMRN. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

Study Design and Demographics

The phase-3 oral fusidic acid double-blind study was conducted at 62 sites in the United States in 716 patients. Patients randomized to treatment with oral fusidic acid received a loading dose of 1,500 mg every 12 hours for two doses, followed by 600 mg every 12 hours thereafter, until the end of a 10-day course of therapy. Patients randomized to treatment with the active comparator, oral linezolid, received 600 mg every 12 hours for 10 days. Randomization was 1:1 and was stratified by type of infection, by age and by prior use of an antibiotic within 36 hours prior to randomization.

Cempra stated that overall, 67.5% of study subjects had an infection associated with intravenous drug abuse. Less than five percent of study subjects received an antibiotic prior to randomization.

Study Results

The primary endpoint ECR was defined as the proportion of patients alive and achieving a ≥ 20% reduction from baseline in lesion size at 48-72 hours after the start of the study drug, without receiving rescue antibiotics. In the study, 87.2% of ITT patients receiving fusidic acid demonstrated ECR compared to 86.6% of ITT patients receiving linezolid.

Fusidic acid also showed comparable efficacy to linezolid in investigator-assessed clinical response in the ITT and clinically evaluable (CE) populations at EOT and PTE visits.

Cempra stated that in the study, microbiological response rates by pathogen were high in both treatment groups in both the microbiological ITT (mITT) and microbiologically-evaluable (ME) patient populations (patients with isolation of a baseline pathogen, who were also clinically evaluable). The most common pathogens identified were Staphylococcus aureus, Streptococcus anginosus group species, Streptococcus pyogenes, and Clostridium species. Notably, the microbiological success rate among fusidic acid recipients in each ME population with methicillin-resistant S. aureus (MRSA) infection was 100% at both the EOT and PTE visits.

Tolerance Points

Cempra noted that Fusidic acid was well tolerated in the study and that the rates of treatment-emergent adverse events (TEAEs) were comparable between treatment groups. The most common TEAEs in both treatment groups were gastrointestinal events. The Company stated that Serious adverse events (SAEs) occurred in six fusidic acid recipients and eight linezolid recipients, and were considered study-drug related in one fusidic acid recipient (vomiting) and in two linezolid recipients.

Way Ahead

Cempra announced that it will submit the full data from this study for presentation at an upcoming scientific forum.

“We are excited that the results of this phase-3 study with fusidic acid confirm the results of our phase-2 study and are consistent with the more than 40 years of experience that the product has accumulated outside the United States,” said David Oldach, M.D., Chief Medical Officer of Cempra.

“We look forward to meeting with the FDA to discuss the next steps required to bring fusidic acid to patients in the United States,” Oldach added.

About Fusidic Acid

Cempra is developing fusidic acid exclusively in the US for ABSSSI and is exploring its use for the long-term oral treatment of refractory bone and joint infections. Fusidic acid is orally active against gram-positive bacteria, including Staphylococcus aureus strains such as healthcare-acquired methicillin-resistant Staphylococcus aureus (HA-MRSA) and community-acquired MRSA.

Stock Performance

At the close of trading session on Friday, February 24, 2017, following the announcement, Cempra’s stock price soared 28.57% to end the day at $4.05. A total volume of 21.59 million shares were exchanged during the session, which was above the 3-month average volume of 2.23 million shares. The Company’s share price has gained 37.29% in the past one month and 44.64% on YTD basis. The stock currently has a market cap of $165.00 million.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 456029

Upcoming AWS Coverage on RSP Permian Post-Earnings Results

LONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. blog coverage looks at the headline from Houston, Texas based Camber Energy, Inc. (NYSE: CEI) as the oil and gas exploration Company announced on February 24, 2017 that its newly formed subsidiary, Camber Permian LLC (CPII) has entered into a definitive Purchase and Sale Agreement with private sellers to acquire oil and gas establishments on lease, covering approximately 15,500 gross acres (13,000 net acres) in the Permian Basin for $11.03 million, under the ‘Arrowhead Project’. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of Camber Energy’s competitors within the Oil & Gas Drilling & Exploration space, RSP Permian, Inc. (NYSE: RSPP), announced on February 01, 2017, that it will release its Q4 and full-year 2016 financial and operating results after the NYSE closes on Monday, February 27, 2017. AWS will be initiating a research report on RSP Permian in the coming days.

Today, AWS is promoting its blog coverage on CEI; touching on RSPP. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

Arrowhead Project: Geographical Considerations

The Arrowhead Project will cover a contiguous block of acreage across the Yoakum and Cochran County line of the Permian Basin inclusive of a completed horizontal San Andres well and a salt-water deposit well, where both are not operational currently. CPII plans to put the San Andres well into production, once the salt-water deposit well kicks into operation. The agreement is accretive to the Company’s growth prospects in the rapidly-emerging horizontal San Andreas play of the Permian Basin. Geographically, the Arrowhead Project differs from previous leases of San Andre’s acreage positions by the Company and is set to expand and diversify the firm’s prospects.

Financial Matters

Concurrent with the execution of the transaction, CPII entered into an exploration agreement with certain undisclosed joint-venture partners. This agreement is set to deliver CPII access to proprietary technical and geological database concerning the Arrowhead Project. The acquisition of the Arrowhead Project will initially be funded by Jaffe Energy, Inc. CPII is structured to be jointly owned by Camber Energy and JEI, where each entity would hold equal stakes. CPII expects to drill and complete the initial wells at the Arrowhead Project during 2017, subject to release of development financing. As a consideration, the joint venture partners have an option to own up to a 10% of working interest, where 5% of which is covered under the lease acquisition. CPII will hold the remaining 90% to 95% working interest in the leasehold, while controlling the operations of the subject properties.

The Permian Basin Contract

On January 03, 2017, Camber Energy, previously known as Lucas Energy, Inc., announced that it has entered into a Lease Acquisition and Participation agreement with a privately-held, Houston, Texas-based oil and gas Company to acquire a leasehold position in the Permian basin in Texas. Under the agreement, Camber Energy initially acquired leasehold comprising of 16,322 gross acres (or 3,630 net mineral acres). Post the execution of the transaction, Camber owned a 90% of working interest in the properties. The Company executed a payout of $1.43 million for the initial leasehold while acquiring operational control over the properties.

This agreement targeted the San Andres formation, found at relatively shallow depths, averaging at about 4,800 feet with a production capacity of about 6 billion barrels of oil to date, where 2 billion barrels were produced from the Central Basin area. The agreement was closed recently, on February 07, 2017.

Growth Prospects

With the execution of this agreement, targeted to close on or before March 30, 2017, the Company is targeting multi-year growth opportunity and an inventory of more than 75 potential drilling locations. At the closing of the transaction, Camber Energy will have a position of about 16,000 net acres in the Permian Basin area. This acquisition is reportedly a step to expand the Company’s foothold in the Permian basin and is set to deliver greater value to shareholders while outperforming market expectations.

Stock Performance

At the close of trading session on Friday, February 24, 2017, Camber Energy’s stock price surged 16.90% to end the day at $0.83. A total volume of 1.75 million shares were exchanged during the session, which was above the 3-month average volume of 729.21 thousand shares. The stock currently has a market cap of $16.90 million.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 456028

Upcoming AWS Coverage on BorgWarner Post-Earnings Results

LONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. announces its post-earnings coverage on Tenneco Inc. (NYSE: TEN). The Company posted its fourth quarter and fiscal 2016 financial results on February 07, 2017. The auto parts maker outperformed revenue and earnings expectations. Register with us now for your free membership at:

http://www.activewallst.com/register/

One of Tenneco’s competitors within the Auto Parts space, BorgWarner Inc. (NYSE: BWA), reported on February 09, 2017, its Q4 and full year results. AWS will be initiating a research report on BorgWarner in the coming days.

Today, AWS is promoting its earnings coverage on TEN; touching on BWA. Get our free coverage by signing up to:

http://www.activewallst.com/register/

Earnings Reviewed

For the quarter ended December 31, 2016, Tenneco reported total revenue of $2.155 billion, up 6% on a y-o-y basis, as a result of stronger global light vehicle revenues which was driven by both the Clean Air and Ride Performance product lines. On a constant currency basis, the Company’s total revenue increased 9% to $2.212 billion, driven by a 13% increase in light vehicle revenue, nearly doubling global light vehicle industry production growth of 7%. The Company’s revenue numbers surpassed analysts’ consensus of $2.09 billion.

Tenneco’s Q4 2016 OE commercial truck and off-highway revenues declined 7% y-o-y, remaining essentially even when compared to Q3 2016 numbers. The Company’s global aftermarket revenue was up 1% versus a year ago.

Tenneco reported Q4 2016 net income of $40 million, or $0.73 per diluted share, which includes an after-tax pension charge of $47 million. In Q4 2015, the Company’s net income was $68 million, or $1.17 per diluted share. Tenneco’s adjusted net income rose to $92 million, or $1.67 per diluted share, versus $80 million, or $1.39 per diluted share, in the year earlier same quarter, exceeding market expectations of $1.42 per share.

Segment Performance

Tenneco reported Q4 2016 EBIT (earnings before interest, taxes and non-controlling interests) of $75 million versus $128 million in Q4 2015. The Company’s adjusted EBIT rose 6% to $157 million, a Q4 record. Tenneco’s EBIT as a percent of revenue was 3.5%, which included a pre-tax pension charge of $72 million, and $10 million in restructuring and related expenses. Adjusted EBIT as a percent of value-add revenue was 9.6%, consistent with a strong performance a year ago. Tenneco stated that both EBIT and EBIT margin results continue to be driven by capitalizing on light vehicle growth in excess of industry production, technology content growth in both product lines, higher aftermarket sales, and a continued focus on launch execution and manufacturing improvements.

For the full year 2016, Tenneco reported total revenue of $8.599 billion. In constant currency, revenue increased 7% to $8.819 billion. The Company’s FY16 EBIT increased to $528 million versus $519 million a year ago. Adjusted EBIT rose 9% to $636 million. Tenneco generated FY16 EBIT as a percent of revenue of 6.1%. Adjusted EBIT as a percent of value-add revenue was 9.7%, up 40 basis points versus a year ago.

Cash Flow & Balance Sheet

Tenneco reported that cash generated by operations in Q4 2016 was $250 million compared to $329 million in Q4 2015. For FY16, the Company’s cash generated by operations was $489 million down from $517 million a year ago, due to the timing of revenue growth at the end of the year and the resulting impact on accounts receivable.

Tenneco’s Capital investments in the reported quarter were $129 million consistent with the level of investment the Company signaled earlier in 2016. These investments are for new or expanded business in North America and Europe and increased capacity in China to support a significant launch in 2017.

In Q4 2016, Tenneco repurchased 1.4 million shares for $79 million. For FY16, the Company repurchased a total of 4.2 million shares for $225 million. The Company’s Board of Directors initiated a quarterly cash dividend of $0.25 with the initial dividend payable on March 23, 2017, to shareholders of record as of March 07, 2017. Additionally, the Board authorized the repurchase of up to $400 million of common shares over the next three years, including the amount remaining on previous authorizations.

Outlook

For Q1 2017, Tenneco expects total revenue growth of 7%, outpacing forecasted light vehicle industry production growth of 3%. The Company expects to better the industry with 4% organic growth, driven by incremental content to meet Tier 3 and Euro 6 emissions regulations, the ramp up of recently launched programs, and Tenneco’s strong position on light vehicle platforms globally.

Full year 2017

Tenneco expects total revenue growth to outpace light vehicle industry production by 4%, resulting in 5% growth in FY17. For full year 2017, Tenneco expects capital expenditures to be between $360 million and $390 million; annual interest expense of about $70 million; and cash taxes between $125 million and $140 million.

In 2018 and 2019, Tenneco expects continued revenue growth, outpacing industry production by 3% to 5% each year.

Stock Performance

On Friday, February 24, 2017, the stock closed the trading session at $65.22, marginally falling 0.17% from its previous closing price of $65.33. A total volume of 315.21 thousand shares have exchanged hands. Tenneco’s stock price advanced 7.68% in the last three months, 15.88% in the past six months, and 43.75% in the previous twelve months. Furthermore, since the start of the year, shares of the Company have gained 4.40%. The stock is trading at a PE ratio of 10.15 and has a dividend yield of 0.38%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 456027